International Conference on Oncology and Cancer Therapeutics Development - (ICOCTD-27)


17th - 18th June, 2027 | Mutare, Zimbabwe

Multi-format (In-person/Virtual)

Submit for Presentation Attendee Registration Conference Brochure
Registration Options →

Explore conference registration categories designed for every mode of participation.

Home About Organizer Call For Paper Paper Submission Author Guidelines Registration Presentation Guidelines Organizing Committee Collaboration Agenda Do's and Dont's Invitation Letter Venue Contact Us

Important Dates

Pre-registration Deadline

18th May, 2027

Paper Submission Deadline

23rd May, 2027

Last Date Of Registration

2nd June, 2027

Date Of Conference

17th - 18th June, 2027

Downloads

Conference Flyer
Sample Abstract
Sample Full Paper

Call for Papers

The (ICOCTD-27) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Oncology, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Emerging cancer therapeutics and treatments
  • Novel drug development in oncology
  • Combination therapies for cancer
  • Immunotherapy advancements in cancer care
  • Targeted therapies in oncology
  • Challenges in cancer drug approval
  • Role of clinical trials in therapeutics
  • Patient access to new treatments
  • Biomarkers in therapeutic decision-making
  • Pharmacogenomics in cancer treatment
  • Cost-effectiveness of cancer therapies
  • Innovations in radiation oncology
  • Palliative care and cancer therapeutics
  • Ethical considerations in drug development
  • Role of technology in cancer therapeutics
  • Long-term outcomes of cancer treatments
  • Global access to cancer therapies
  • Patient adherence to cancer treatment
  • Future trends in cancer therapeutics
  • Collaboration in drug development research

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.

Submit Your Paper Today Register Early & Reserve Your Slot